DARUNAVIR

Generic: DARUNAVIR

Aurobindo Pharma LimitedManufacturer
ORALRoute
DARUNAVIR PROPYLENE GLYCOLATEActive Substance
2023-11-28Original Approval

DARUNAVIR is FDA application ANDA210677, sponsored by AUROBINDO PHARMA LTD. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Top Reported Reactions

1
DRUG INTERACTION
704 reports
2
FOETAL EXPOSURE DURING PREGNANCY
500 reports
3
VIROLOGIC FAILURE
328 reports
4
MATERNAL EXPOSURE DURING PREGNANCY
313 reports
5
DRUG RESISTANCE
289 reports
6
OFF LABEL USE
248 reports
7
DEATH
238 reports
8
DRUG INEFFECTIVE
238 reports
9
EXPOSURE DURING PREGNANCY
231 reports
10
TREATMENT FAILURE
224 reports